132 related articles for article (PubMed ID: 24785546)
1. Predictors of pocket hematoma in patients on antithrombotic therapy undergoing cardiac rhythm device implantation: insights from the FinPAC trial.
Nammas W; Raatikainen MJ; Korkeila P; Lund J; Ylitalo A; Karjalainen P; Virtanen V; Koivisto UM; Utriainen S; Vasankari T; Koistinen J; Airaksinen KE
Ann Med; 2014 May; 46(3):177-81. PubMed ID: 24785546
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
[TBL] [Abstract][Full Text] [Related]
3. The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation.
Thal S; Moukabary T; Boyella R; Shanmugasundaram M; Pierce MK; Thai H; Goldman S
Pacing Clin Electrophysiol; 2010 Apr; 33(4):385-8. PubMed ID: 20059711
[TBL] [Abstract][Full Text] [Related]
4. Safety of pacemaker and implantable cardioverter-defibrillator implantation during uninterrupted warfarin treatment--the FinPAC study.
Airaksinen KE; Korkeila P; Lund J; Ylitalo A; Karjalainen P; Virtanen V; Raatikainen P; Koivisto UM; Koistinen J
Int J Cardiol; 2013 Oct; 168(4):3679-82. PubMed ID: 23849104
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular implantable electronic device implantation with uninterrupted dabigatran: comparison to uninterrupted warfarin.
Jennings JM; Robichaux R; McElderry HT; Plumb VJ; Gunter A; Doppalapudi H; Osorio J; Yamada T; Kay GN
J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1125-9. PubMed ID: 23889767
[TBL] [Abstract][Full Text] [Related]
6. Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).
Deharo JC; Sciaraffia E; Leclercq C; Amara W; Doering M; Bongiorni MG; Chen J; Dagres N; Estner H; Larsen TB; Johansen JB; Potpara TS; Proclemer A; Pison L; Brunet C; Blomström-Lundqvist C;
Europace; 2016 May; 18(5):778-84. PubMed ID: 27226497
[TBL] [Abstract][Full Text] [Related]
7. Systematic Implantation of Pacemaker/ICDs under Active Oral Anticoagulation Irrespective of Patient's Individual Preoperative Thromboembolic Risk.
Cano Ó; Andrés A; Jiménez R; Osca J; Alonso P; Rodríguez Y; Sancho-Tello MJ; Olagüe J; Castro JE; Salvador A; Martínez-Dolz L
Pacing Clin Electrophysiol; 2015 Jun; 38(6):723-30. PubMed ID: 25682988
[TBL] [Abstract][Full Text] [Related]
8. Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat Hemostat versus standard of care.
Ohlow MA; Lauer B; Buchter B; Schreiber M; Geller JC
Int J Cardiol; 2012 Sep; 159(3):177-80. PubMed ID: 21376404
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.
Lamberts M; Gislason GH; Olesen JB; Kristensen SL; Schjerning Olsen AM; Mikkelsen A; Christensen CB; Lip GY; Køber L; Torp-Pedersen C; Hansen ML
J Am Coll Cardiol; 2013 Sep; 62(11):981-9. PubMed ID: 23747760
[TBL] [Abstract][Full Text] [Related]
10. Perioperative anticoagulation management in patients on chronic oral anticoagulant therapy undergoing cardiac devices implantation: a meta-analysis.
Du L; Zhang Y; Wang W; Hou Y
Pacing Clin Electrophysiol; 2014 Nov; 37(11):1573-86. PubMed ID: 25234639
[TBL] [Abstract][Full Text] [Related]
11. Risk of hematoma complications after device implant in the clopidogrel era.
Kutinsky IB; Jarandilla R; Jewett M; Haines DE
Circ Arrhythm Electrophysiol; 2010 Aug; 3(4):312-8. PubMed ID: 20558847
[TBL] [Abstract][Full Text] [Related]
12. Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).
Malagù M; Trevisan F; Scalone A; Marcantoni L; Sammarco G; Bertini M
Am J Cardiol; 2017 Apr; 119(7):1036-1040. PubMed ID: 28153344
[TBL] [Abstract][Full Text] [Related]
13. Cardiac resynchronization therapy device implantation in patients with therapeutic international normalized ratios.
Ghanbari H; Feldman D; Schmidt M; Ottino J; Machado C; Akoum N; Wall TS; Daccarett M
Pacing Clin Electrophysiol; 2010 Apr; 33(4):400-6. PubMed ID: 20180915
[TBL] [Abstract][Full Text] [Related]
14. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.
Wiegand UK; LeJeune D; Boguschewski F; Bonnemeier H; Eberhardt F; Schunkert H; Bode F
Chest; 2004 Oct; 126(4):1177-86. PubMed ID: 15486380
[TBL] [Abstract][Full Text] [Related]
15. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
[TBL] [Abstract][Full Text] [Related]
16. Perioperative hematoma with subcutaneous ICD implantation: Impact of anticoagulation and antiplatelet therapies.
Sheldon SH; Cunnane R; Lavu M; Parikh V; Atkins D; Reddy YM; Berenbom LD; Emert MP; Pimentel R; Dendi R; Lakkireddy DR
Pacing Clin Electrophysiol; 2018 Jul; 41(7):799-806. PubMed ID: 29659027
[TBL] [Abstract][Full Text] [Related]
17. [Hemorrhagic risk of different perioperative anticoagulation protocols in patients implanted with a cardiac pacemaker or defibrillator: retrospective analysis in patients implanted in a community hospital].
Amara W; Ben Youssef I; Kamel J; Ghrissi I; Faron M; Khouadja A; Sergent J
Ann Cardiol Angeiol (Paris); 2009 Nov; 58(5):265-71. PubMed ID: 19833318
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
Rubboli A; Milandri M; Castelvetri C; Cosmi B
Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950
[TBL] [Abstract][Full Text] [Related]
19. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation.
Sarafoff N; Ndrepepa G; Mehilli J; Dörrler K; Schulz S; Iijima R; Byrne R; Schömig A; Kastrati A
J Intern Med; 2008 Nov; 264(5):472-80. PubMed ID: 18624903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
